Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | PPIA | P62937 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.37 |
| ▸ | CXCR2 | P25025 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | IL2 | P60568 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6507096 | 0.94 | KMT2A (0.52) | MEN1KMT2AATMUSP2MAPT | |
| SCHEMBL6505906 | 0.92 | MEN1 (0.60) | MEN1KMT2AATMUSP2MAPT | |
| SCHEMBL6514583 | 0.90 | MEN1 (0.52) | MEN1KMT2AATMUSP2MAPT | |
| SCHEMBL6505628 | 0.86 | KMT2A (0.57) | MEN1KMT2AATMUSP2MAPT | |
| SCHEMBL6502474 | 0.85 | ATM (0.53) | MEN1KMT2AATMUSP2MAPT | |
| SCHEMBL6507276 | 0.85 | KMT2A (0.49) | MEN1KMT2AATMUSP2MAPT | |
| SCHEMBL5316163 | 0.83 | ATM (0.51) | MEN1KMT2AATMUSP2MAPT | |
| SCHEMBL6504414 | 0.83 | KMT2A (0.52) | MEN1KMT2AATMUSP2MAPT | |
| SCHEMBL6511572 | 0.82 | KMT2A (0.60) | MEN1KMT2AATMUSP2MAPT | |
| SCHEMBL5310875 | 0.81 | ATM (0.53) | MEN1KMT2AATMUSP2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050159599-A1 | Cyclic compound, process for producing the same, and pest control agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-21 | — | — | US | disclosed |
| EP-1481972-A1 | CYCLIC COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PEST CONTROL AGENT | Sumitomo Chemical Takeda Agro Company, Limited (JP) | 2004-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159599-A1 | Cyclic compound, process for producing the same, and pest control agent | CNPY2, CNPY3, HAX1 | MEN1 2593/4885KMT2A 1362/4885ATM 2564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.